Citigroup Inc GYRE THERAPEUTICS INC Transaction History

Citigroup Inc

  • $196 Billion
  • Q2 2025
Number of Shares
5,937
Previous 4,853 22.34%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
BUY
N/A
1,084 Added 22.34%
5,937 $0
Q1 2025

May 12, 2025
SELL
N/A
-546 Reduced 10.11%
4,853 $0
Q4 2024

Feb 12, 2025
BUY
N/A
323 Added 6.36%
5,399 $0
Q3 2024

Nov 12, 2024
BUY
N/A
3,514 Added 224.97%
5,076 $0
Q2 2024

Aug 12, 2024
SELL
N/A
-10,606 Reduced 87.16%
1,562 $0
Q1 2024

May 10, 2024
BUY
N/A
4,420 Added 57.05%
12,168 $0
Q4 2023

Feb 09, 2024
BUY
N/A
7,748 New
7,748 $0
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email